Skip to main content

Table 2 NLR among several clinicopathological variables

From: Neutrophils to lymphocytes ratio as a useful prognosticator for stage II colorectal cancer patients

Parameter NLR (Median + IR) p value
Gender
 Male 2.59 (2.05–3.32) NS
 Female 2.51 (1.87–3.69)
Age
  ≥ 72 years 2.72 (2.14–3.76) 0.016
  < 72 years 2.41 (1.82–3.16)
Primary tumor
 Right colon 2.67 (2.13–3.76)  
 Left colon 2.65 (1.89–3.42)
 Rectum 2.48 (1.81–3.08)
 Right VS Left colon 2.67 (2.13–3.76) VS 2.49 (1.85–3.24) NS
 Colon VS Rectum 2.67 (2.10–3.68) VS 2.48 (1.81–3.08) NS
Differentiation
 Low 2.7 (2.2–3.44) NS
 Medium + High 2.51 (1.88–3.4)
T
 T1 1.88 (1.53–2.98) NS
 T2 2.49 (1.85–3.14)
 T3 2.6 (2.0–3.43)
 T4 2.76 (2.27–5.22)
N
 N0 2.58 (1.92–3.37) NS
 N1 2.34 (1.85–3.45)
 N2 2.78 (2.29–3.95)
No of lymph node harvested
  < 12 2.37 (2.09–3.28) NS
  ≥ 12 2.58 (1.92–3.43)
No of infiltrated lymph nodes
 0 (n = 198) 2.58 (1.96–3.43) NS
 1 (n = 21) 2.22 (1.73–3.82)
  ≥ 2 (n = 77) 2.55 (1.91–3.33)
Stage
 Stage I 2.26 (1.74–2.87) 0.049
 Stage II 2.67 (2.16–3.45)
 Stage III 2.55 (1.96–3.60)
 Stage I VS Stage II + III 2.26 (1.74–2.87) VS 2.62 (2.07–3.48)
Perineural invasion
 No 2.53 (1.91–3.30) < 0.001
 Yes 3.45 (2.24–6.00)
Vascular invasion
 No 2.54 (1.91–3.36) 0.034
 Yes 2.68 (2.17–4.18)
Lymphatic invasion
 No 2.53 (1.91–3.40) NS
 Yes 2.63 (2.12–3.69)
Recurrence
 No 2.54 (1.96–3.37) NS
 Yes 2.79 (1.83–4.03)
Site of recurrence
 Local (n = 15) 2.11 (1.56–4.03) NS
 Distant (n = 16) 3.05 (2.07–3.89)
\